3 results
Primary ObjectiveThe primary objective of this study is to evaluate the effect of 12 weeks of treatment with 2 different doses of oral AQX-1125 (100 mg or 200 mg) administered once daily compared to placebo on the change from Baseline (Visit 2) to…
In this non-inferiority study, we aim to identify the diagnostic value of indocyanine green (ICG) fluorescence imaging for SLN mapping versus the standard-of-care 99mTc in the SLN procedure for breast cancer patients.
The aim of this study is to investigate if non-invasive HD-tDCS brain stimulation can be used to stimulate thought suppression in healthy individuals (experiment 1) and in individuals with heightened levels of anxiety (experiment 2).